Reach Us +1-504-608-239
Aims and Scope - Immunogenetics: Open Access

Immunogenetics: Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Aims and Scope


The main aim of the Immunogenetics: Open access journal is to publish high quality research works and provide Open Access to the articles using this platform. The Journal offers a rapid and time bound review and publication that freely disseminates research findings related to Immunogenetics. Immunogenetics: Open access journal caters to the requirements of the medical practitioners, researchers, lab professionals, students, academicians, and industry that is involved in Medical and clinical studies. No matter how prestigious or popular; it increases the visibility and impact of published work. It increases convenience, reach, and retrieval power. Free online literature software facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis.


Immunogenetics: Open access brings articles in all areas related to immunogenetics, immunogenicity, human immunogenetics, diabetes immunogenetics, HIV immunogenetics, multiple sclerosis immunogenetics, current research on immunogenetics, genes and immunity, natural killer cells immunity, immunogenetics and histocompatibility, genetic control of immune cell activation, human leukocyte antigens, genetic control of immuneresponse, immunogentics of cell interaction, immunogenetics of tissue differentiation, immunogenetics of tissue development, phylogeny of allo antigens, disease suceptibility, genetics of allo antigens, etc.


All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Immunogenetics: Open access strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. Immunogenetics: Open access journal will keep up-to- date with latest advances in the field of immunogenetics. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Immunogenetics: Open access are freely accessible to everyone immediately after publication. The Journal supports the Bethesda Statement on Open Access Publishing.


Leave Your Message 24x7